-
Provisions for the Lot Release of Biological Products
2022-06-30
Provisions for the Lot Release of Biological Products, deliberated and adopted at the 11th executive meeting in 2020 of State Administration for Market Regulation on November 19, 2020, is hereby promulgated and shall go into effect as of March 1, 2021.
-
Provisions for the Supervision and Administration of Drug Manufacturing
2022-06-30
The Provisions for the Supervision and Administration of Drug Manufacturing, adopted at the first executive meeting of the State Administration for Market Regulation in 2020 held on January 15, 2020, is hereby promulgated and shall come into effect as of July 1, 2020.
-
Provisions for Drug Registration
2022-06-30
The Provisions for Drug Registration, adopted at the first executive meeting of the State Administration for Market Regulation on January 15, 2020, is hereby promulgated and shall come into force as of July 1, 2020.
-
Provisions for Crude Drugs Importation
2022-06-30
The Provisions are applicable to the application, approval, filing, port testing as well as supervision and administration of crude drugs importation
-
Good Supply Practice for Drugs
2022-06-30
Issued in Decree No. 20 of former CFDA on April 30, 2000, first revision in ministerial meeting of former Ministry of Health on November 6, 2012, second revision in the executive meeting of former CFDA on May 18, 2015, and amended according to the Decision to Amend the Good Supply Practice for Drugs of former CFDA on June 30, 2016